Advances in Traditional Medicine

Kyung Hee Oriental Medicine Research Center (경희대학교 융합한의과학연구소)
권호 표지
DOI QR코드

DOI QR Code

Anti-inflammatory effect of Samultang in human mast cell line HMC-1

  • Published : 2006.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Samultang has been believed for prevention and remedy various blood diseases such as menstrual irregularity, anemia, and metrorrhagia. However, the mechanism that accounts for anti-inflammatory effects of the Samultang is still not fully understood. This study was designed to evaluate whether and how the Samultang could modulate the production of pro-inflammatory cytokines in phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore A23187 treated-human mast cell line, HMC-1. Samultang inhibited the production of tumor necrosis factor $(TNF)-\alpha$, interleukin (IL)-6, granulocyte macrophage colony stimulating factor (GM-CSF), and vascular endothelial growth factor (VEGF) in HMC-1. Maximal inhibition rate of $TNF-\alpha$, IL-6, GM-CSF, and VEGF by 0.1 mg/ml Samultang was about $70.73{\pm}3.0%,\;51.49{\pm}4.14%,\;54.03{\pm}2.09%$, and $47.95{\pm}7.86%$, respectively. Samultang partially blocked PMA plus A23187-induced cyclooxygenase (COX)-2 expression. In addition, Samultang inhibited activation of nuclear factor (NF)-kB, and extracellular signal-regulated kinase (ERK) activation. These results suggest that anti-inflammatory effect of Samulatng may be mediated by the suppression of cytokine production and COX-2 activation via down-regulation of NF-kB and ERK activation.

Keywords

References

  1. Abdel-Majid RM, Marshall JS. (2004) Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J. Immunol. 172, 1227-1236.
  2. Appleton I, Brown NJ, Willis D, Colville-Nash PR, Alam C, Brown JR, Willoughby DA. (1996) The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J. Pathol. 180, 90-94. https://doi.org/10.1002/(SICI)1096-9896(199609)180:1<90::AID-PATH615>3.0.CO;2-D
  3. Artuc M, Hermes B, Steckelings UM, Grutzkau A, Henz BM. (1999) Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders? Exp. Dermatol. 8, 1-16. https://doi.org/10.1111/j.1600-0625.1999.tb00342.x
  4. Barchowsky A, Frleta D, Vincenti MP. (2000) Integration of the NF-kappaB and mitogen-activated protein kinases/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 12, 1469-1479. https://doi.org/10.1006/cyto.2000.0743
  5. Barnes PJ, Adcock IM. (1997) NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol. Sci. 18, 46-50.
  6. Barnes PJ, Karin M. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New Engl. J. Med. 336, 1066-1071. https://doi.org/10.1056/NEJM199704103361506
  7. Bochenek G, Nizankowska E, Gielicz A, Swierczynska M, Szczeklik A. (2004) Plasma 9alpha, 11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 59, 459-464. https://doi.org/10.1136/thx.2003.013573
  8. Bradding P, Holgate ST. (1999) Immunopathology and human mast cell cytokines. Crit. Rev. Oncol. Hematol. 31, 119-133. https://doi.org/10.1016/S1040-8428(99)00010-4
  9. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. (1992) Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89, 958-967. https://doi.org/10.1016/0091-6749(92)90218-Q
  10. Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW. (1988) Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 2, 706-709.
  11. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, Bevilacqua G, Campani D. (2004) Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J. Clin. Pathol. 57, 630-636. https://doi.org/10.1136/jcp.2003.014498
  12. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M. (1995) Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55, 4140-4145.
  13. Gajewska BD, Wiley RE, Jordana M. (2003) GM-CSF and dendritic cells in allergic airway inflammation: basic mechanisms and prospects for therapeutic intervention. Curr. Drug Targets Inflamm. Allergy 2, 279-292. https://doi.org/10.2174/1568010033484052
  14. Galli SJ. (1993) New concepts about the mast cell. N. Engl. J. Med. 328, 257-265. https://doi.org/10.1056/NEJM199301283280408
  15. Grutzkau A, Kruger-Krasagakes S, Baumeister H, Schwarz C, Kogel H, Welker P, Lippert V, Henz BM, Moller A. (1998) Synthesis, Storage, and Release of vascular endothelial growth factor/vascular permeability factor (BEGF/VPF) by human mast cells; Implications for the biological significance of VEGF206. Mol. Biol. Cell 9, 875-884.
  16. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ. (2003) Selective interactio of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770.
  17. Keystone EC. (2001) Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 27, 427-443. https://doi.org/10.1016/S0889-857X(05)70211-8
  18. Kim MS, Yi JM, Kim SH, Hong SH, Kim HM. (2004) Madimadi, Korean folk medicine, blocks TNF-${\alpha}$, IL-1${\beta}$, and IL-8 production by activated human immune cells. Cytokine 25, 179-186. https://doi.org/10.1016/j.cyto.2003.11.016
  19. Kong G, Kim EK, Kim WS, Lee KT, Lee YW, Lee JK, Paik SW, Rhee JC. (2002) Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer. J. Gastroenterol. Hepatol. 17, 914-921. https://doi.org/10.1046/j.1440-1746.2002.02829.x
  20. Kruger-Krasagakes S, Czarnetzki BM. (1995) Cytokine production by human mast cells. Exp. Dermatol. 4, 250-254. https://doi.org/10.1111/j.1600-0625.1995.tb00253.x
  21. Nilsson G, Svensson V, Nilsson K. (1995) Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand. J. Immunol. 42, 76-81. https://doi.org/10.1111/j.1365-3083.1995.tb03628.x
  22. Nishimoto N. (2005) Cytokine signal regulation and autoimmune disorders. Autoimmunity 38, 359-367. https://doi.org/10.1080/08916930500124106
  23. Norrby K. (2002) Mast cells and angiogenesis. APMIS 110, 355-371. https://doi.org/10.1034/j.1600-0463.2002.100501.x
  24. Oh JW, Lee HB, Kim CR, Yum MK, Koh YJ, Moon SJ, Kang JO, Park IL. (1999) Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma. Ann. Allergy Asthma Immunol. 82, 491-496. https://doi.org/10.1016/S1081-1206(10)62727-5
  25. Shapiro L, Dinarello CA. (1995) Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. U.S.A. 92, 12230-12234. https://doi.org/10.1073/pnas.92.26.12230
  26. Shin HY, Lee EH, Kim CY, Shin TY, Kim SS, Song YS, Lee KN, Hong SH, Kim HM. (2003) Anti-inflammatory activity of Korean folk medicine purple bamboo salt. Immunopharm. Immunotoxicol. 25, 377-384. https://doi.org/10.1081/IPH-120024505
  27. Sillaber C, Bevec D, Butterfield JR, Heppner C, Valenta R Scheiner O, Kraft D, Lechner K, Bettelheim P, Valent P. (1993) Tumor necrosis factor-${\alpha}$, and interleukin-1${\beta}$ mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp. Hematol. 21, 1271-1275.
  28. So HS, Oh J, Chung YT, Moon YJ, Kim DH, Moon BS, Lee HS, Baek SW, Park C, Lim YS, Kim MS, Park RK. (2000) The water extract of Samultang protects the Lipopolysaccharide (LPS)/Phorbol 12-myristate 13-acetate (PMA)-induced damage and nitric oxide production of C6 glial cells via down-regulation of NF-${\kappa}$B. Gen. Pharmacol. 34, 303-310. https://doi.org/10.1016/S0306-3623(00)00073-2
  29. Soloperto M, Mattoso VL, Fasoli A, Mattoli SA. (1991) Bronchial epithelial cell-derived factor in asthma that promotes eosinophil activation and survival as GM-CSF. Am. J. Physiol. 260, L530-L538.
  30. Stassen M, Muller C, Arnold M, Hultner L, Klein-Hessling S, Neudorfl C, Reineke T, Serfling E, Schmitt E. (2001) IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J. Immunol. 166, 4391-4398.
  31. Taylor PC. (2001) Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases. Mol. Biotechnol. 19, 153-168. https://doi.org/10.1385/MB:19:2:153
  32. Watkins LR, Maier SF. (1999) Implications of immune-to-brain communication for sickness and pain. Proc. Natl. Acad. Sci. U.S.A. 96, 7710-7713. https://doi.org/10.1073/pnas.96.14.7710